http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2694761-C9
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d86097a4bf6191f631e5c7a44924630a |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5152 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001176 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2014-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee6128fafe5cc8406173b8e0e1180fd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53823e0cd89b39e1f76f15ab702e9233 |
| publicationDate | 2019-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2694761-C9 |
| titleOfInvention | Therapeutic cancer vaccine based on stress proteins as immunogens |
| abstract | FIELD: medicine.SUBSTANCE: invention describes a method for preparing compositions containing tumour cell stress proteins, which involves the following steps: obtaining tumour cells in a culture medium; effect on tumour cells from stage 1) with stress so that these cells generate stress proteins in response to stress; obtaining or extracting stress cells and/or stress proteins; treatment of stressed tumour cells and/or obtained stress proteins by a molecule or a method capable of making stress proteins immunogenic, preferably hapten or by haptenilation method.EFFECT: invention also describes pharmaceutical compositions containing tumour cell stress proteins and/or tumour cells containing stress proteins which have become immunogenic, particularly haptenilised, as well as a pharmaceutically acceptable excipient.27 cl, 6 dwg, 6 ex |
| priorityDate | 2013-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 470.